Gastric, Gastroesophageal Junction and Esophageal Cancer | Zev Wainberg, MD, MSc

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastric, Gastroesophageal Junction and Esophageal Cancer — Faculty Presentation 1: Recent Advances in the Use of Immune Checkpoint Inhibitors for Gastric, Gastroesophageal Junction (GEJ) and Esophageal Tumors — Zev Wainberg, MD, MSc CME information and select publications